Nokia surges on patent dispute settlement with Apple >>> READ MORE


Amgen, Inc. (AMGN) Offers Money-Back Guarantee to Heart Attack Victims on Repatha

Amgen (AMGN) is willing to offer a money-back guarantee to patients that suffer a heart attack while on its cardiovascular drug Repatha. More 

Amgen, Inc. (AMGN) Stock Crashed. Here’s How to Trade It.

Biotech stock Amgen (AMGN) is reeling Friday after disappointing heart study results. Here's how to capitalize on the pain in AMGN stock. More 

Is Now the Time to Buy Into These 5 Biotech ETFs?

After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out More 

3 Ways to Play This Biotech Stocks Dip

Biotech stocks have retraced to an attractive buy point. Consider these three plays on XBI, CELG and AMGN. More 

Should You Buy Amgen, Inc. (AMGN) Stock? 3 Pros, 3 Cons

Amgen stock is back near all-time highs. Will its biosimilar portfolio power it higher, or will legal disputes hold the stock back? More 

9 Top Pharmaceutical Stocks to Buy for the Dividends

Fans of dividends don't have to completely abandon all hope for growth too -- these top pharmaceutical stocks offer the best of both worlds. More 

3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), GoPro Inc (GPRO) and Visa Inc (V)

Amgen, Inc. (AMGN), GoPro Inc (GPRO) and Visa Inc (V) all reported on their latest quarter Thursday. Here's how they performed. More